You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Sarcoidosis
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:diseases:sarcoidosis [12.27.2018] – [Autoimmune vs. immunosuppressed] sallieqhome:diseases:sarcoidosis [02.28.2019] – [Data] sallieq
Line 80: Line 80:
 Kanchwala //et al.// showed that patients with sarcoidosis expressed the antimicrobial peptide cathelicidin less than healthy subjects, and that sicker sarcoidosis patients expressed it least of all.((Kanchwala, A., B. Barna, et al. (2009). [[http://meeting.chestpubs.org/cgi/content/abstract/136/4/127S-a|Deficiencies of cathelicidin and vitamin D accompany disease severity in sarcoidosis]].)) Wiken //et al.// showed that there was a reduced TLR2 mRNA expression in patients with Lofgren's syndrome (a type of acute sarcoidosis).(({{pubmed>long:20813038}})) Note that TLR2 (which the Marshall Pathogenesis theorizes is downregulated in autoimmune disease states) is expressed by the VDR.  Kanchwala //et al.// showed that patients with sarcoidosis expressed the antimicrobial peptide cathelicidin less than healthy subjects, and that sicker sarcoidosis patients expressed it least of all.((Kanchwala, A., B. Barna, et al. (2009). [[http://meeting.chestpubs.org/cgi/content/abstract/136/4/127S-a|Deficiencies of cathelicidin and vitamin D accompany disease severity in sarcoidosis]].)) Wiken //et al.// showed that there was a reduced TLR2 mRNA expression in patients with Lofgren's syndrome (a type of acute sarcoidosis).(({{pubmed>long:20813038}})) Note that TLR2 (which the Marshall Pathogenesis theorizes is downregulated in autoimmune disease states) is expressed by the VDR. 
  
-===== Statistics =====+===== Data =====
  
 //from DJ in California//  //from DJ in California// 
Line 88: Line 88:
  
 I tried my best to be unbiased as I was expecting to see about a 20% improvement in health of members, or in other words a 20-25% success rate. I was intending to compare this to the 10% success rate I found done on the use of prednisone to treat Sarcoidosis. That double blind report shows that 10% treated with prednisone achieve remission. (BTW remission in Sarcoidosis as far as I can find out is measured rather subjectively)  I tried my best to be unbiased as I was expecting to see about a 20% improvement in health of members, or in other words a 20-25% success rate. I was intending to compare this to the 10% success rate I found done on the use of prednisone to treat Sarcoidosis. That double blind report shows that 10% treated with prednisone achieve remission. (BTW remission in Sarcoidosis as far as I can find out is measured rather subjectively) 
 +
 The following information is what I found:  The following information is what I found: 
 +
 Sarcoidosis: 236 members; 179 success; 25 no success; 32 unsure  Sarcoidosis: 236 members; 179 success; 25 no success; 32 unsure 
- 
-Other Th1 diseases: 184 members; 110 success; 30 no success 44 unsure  
  
  
 TOTALS: 864 members;573 report success; 119 report no success; and for 172 results are not clear.  TOTALS: 864 members;573 report success; 119 report no success; and for 172 results are not clear. 
 +
 SUCCESS RATES:  SUCCESS RATES: 
 Over all success rate 66.32% Over all unsuccessful 13.77% Over all unsure 19.91%  Over all success rate 66.32% Over all unsuccessful 13.77% Over all unsure 19.91% 
Line 253: Line 254:
  
 The reported frequency of ocular manifestations for sarcoidosis varies according to the source and group studied, but may be as high as 70%.(({{pubmed>long:18021432}}))  In the eye, the common sites of involvement are the skin of eyelid, conjunctiva, uveal tract, retina, optic nerve and lacrimal gland.(({{pubmed>long:11217257}})) Common symptoms of ocular sarcoidosis include: The reported frequency of ocular manifestations for sarcoidosis varies according to the source and group studied, but may be as high as 70%.(({{pubmed>long:18021432}}))  In the eye, the common sites of involvement are the skin of eyelid, conjunctiva, uveal tract, retina, optic nerve and lacrimal gland.(({{pubmed>long:11217257}})) Common symptoms of ocular sarcoidosis include:
-  * uveitis – Swelling and irritation of the uvea, the middle layer of the eye. Most common is anterior uveitis, however, over a quarter of patients will have inflammation at the posterior of the eye, including retinitis pars planitis. according to the  [[http://www.clevelandclinic.org/eye/patient_info/uveitis.asp|Cleveland Clinic]], "Complications of uveitis may include glaucoma, cataract, abnormal blood vessel growth, fluid within the retina and vision loss."+  * uveitis – Swelling and irritation of the uvea, the middle layer of the eye. Most common is anterior uveitis, however, over a quarter of patients will have inflammation at the posterior of the eye, including retinitis pars planitis. according to the Cleveland Clinic, "Complications of uveitis may include glaucoma, cataract, abnormal blood vessel growth, fluid within the retina and vision loss."
   * Sjogren's (Sicca) – Sjogren's and sarcoidosis are both described in the standard literature as a collection of symptoms. Sjogren's is known to be related to diseases such as rheumatoid arthritis, sarcoidosis, lupus, scleroderma and polymyositis. Many sarcoidosis patients manifest the same symptoms as described in Sjogren's syndrome (dry eyes and mouth, decreased tears and saliva, and resulting dental caries). Sjogren's is reportedly seen in about half of patients.   * Sjogren's (Sicca) – Sjogren's and sarcoidosis are both described in the standard literature as a collection of symptoms. Sjogren's is known to be related to diseases such as rheumatoid arthritis, sarcoidosis, lupus, scleroderma and polymyositis. Many sarcoidosis patients manifest the same symptoms as described in Sjogren's syndrome (dry eyes and mouth, decreased tears and saliva, and resulting dental caries). Sjogren's is reportedly seen in about half of patients.
   * photosensitivity   * photosensitivity
Line 546: Line 547:
 huh ! link removed from gif huh ! link removed from gif
  Source: [[http://meeting.chestpubs.org/cgi/content/abstract/136/4/127S-a|Kanchwala et al.]]}}]  Source: [[http://meeting.chestpubs.org/cgi/content/abstract/136/4/127S-a|Kanchwala et al.]]}}]
 +
 +[[http://www.clevelandclinic.org/eye/patient_info/uveitis.asp|Cleveland Clinic]]
  
 smoking reduces risk smoking reduces risk
home/diseases/sarcoidosis.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.